Androgenetic Alopecia
📧 Sign up to get email alerts when something new happens for Androgenetic Alopecia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-02-28FDA Approved: WOMENS ROGAINE UNSCENTED — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application for Women's Rogaine Unscented (minoxidil) submitted by Kenvue Brands LLC.
-
CLINICAL_TRIALS trial_result · 2014-02-20Clinical Trial Update: A Randomized, Double-blind Clinical Trial to Evaluate the Safety and Efficacy of the X5 HairLaser for the Treatment of Androgenetic Alopecia in Males [NA]
This document reports the completion of a randomized, double-blind clinical trial evaluating the safety and efficacy of the X5 HairLaser for…
-
FDA approval · 2014-01-31FDA Approved: PROPECIA — Supplemental Application (Organon LLC)
FDA approved a supplemental application for PROPECIA (finasteride) submitted by Organon LLC. The approval pertains to changes in the product…
-
FDA approval · 2013-12-13FDA Approved: WOMENS ROGAINE UNSCENTED — Supplemental Application (Kenvue Brands LLC)
The FDA approved a supplemental application for WOMENS ROGAINE UNSCENTED (minoxidil), enabling an unscented topical formulation for women.
-
CLINICAL_TRIALS trial_result · 2013-12-12Clinical Trial Update: A Study to Evaluate the Superiority, Efficacy and Tolerability of Combination Pantovigar With 2% Minoxidil vs 2% Minoxidil in Women With Female Pattern Hair Loss [Phase 2]
A Phase 2 randomized trial comparing Pantovigar plus 2% Minoxidil versus 2% Minoxidil alone in women with female pattern hair loss/androgene…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-11-07Clinical Trial Update: Effectiveness and Safety of Minoxidil Foam Versus Placebo Foam for Androgenetic Alopecia [Phase 2]
Phase 2 trial evaluating the effectiveness and safety of minoxidil topical foam versus placebo foam in androgenetic alopecia; the study has …
-
FDA approval · 2013-11-05FDA Approved: FINASTERIDE — Original Application (Accord Healthcare, Inc.)
FDA approved Accord Healthcare, Inc.'s FINASTERIDE as an Original Application (ANDA), authorizing the marketing of a generic FINASTERIDE pro…
-
FDA approval · 2013-11-05FDA Approved: FINASTERIDE — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for finasteride from Aurobindo Pharma Limited, authorizing a generic version of finasteride for US mar…
-
CLINICAL_TRIALS trial_result · 2013-09-25Clinical Trial Update: Efficacy and Safety of Mesotherapy With Minoxidil 0.5%/2ml for Androgenetic Alopecia in Female Patients [Phase 3]
Phase 3 clinical trial update evaluating mesotherapy with minoxidil 0.5%/2 mL for female pattern alopecia, assessing efficacy and safety. Sp…
-
CLINICAL_TRIALS trial_result · 2013-08-30Clinical Trial Update: Safety and Pharmacokinetics Study of New Formulation of Bimatoprost in Patients With Alopecia [Phase 1]
Phase 1 safety and pharmacokinetics evaluation of a new formulation of bimatoprost in patients with alopecia. Results were posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-07-11Clinical Trial Update: A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0006931) [Phase 2]
Phase 2 study evaluating autologous mixed population dermal cell injections for androgenetic alopecia has completed.
-
CLINICAL_TRIALS trial_result · 2013-07-11Clinical Trial Update: A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004542) [Phase 2]
A Phase 2 trial by Aderans Research Institute evaluated autologous dermal sheath cup cell injections for androgenetic alopecia and related p…
-
CLINICAL_TRIALS trial_result · 2013-07-11Clinical Trial Update: A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0005995) [Phase 2]
Phase 2 trial evaluating injections of autologous mixed population of dermal cells for androgenetic alopecia completed.
-
CLINICAL_TRIALS trial_result · 2013-07-11Clinical Trial Update: A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004541) [Phase 2]
Phase 2 study evaluating injections of autologous dermal and epidermal cells for androgenetic alopecia (male and female pattern baldness) ha…
-
CLINICAL_TRIALS trial_result · 2013-07-11Clinical Trial Update: A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004512) [Phase 2]
Phase 2 clinical trial evaluating autologous dermal and epidermal cell injections for androgenetic alopecia has completed.
-
CLINICAL_TRIALS trial_result · 2013-07-11Clinical Trial Update: A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004669) [Phase 2]
A Phase 2 clinical trial evaluating injections of autologous dermal and epidermal cells for hair loss, including androgenetic alopecia and p…
-
CLINICAL_TRIALS trial_result · 2013-07-11Clinical Trial Update: A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002899) [Phase 2]
This update notes the completion of a Phase 2 study evaluating injections of autologous dermal and epidermal cells into the balding scalp of…
-
FDA approval · 2013-07-01FDA Approved: FINASTERIDE — Original Application (Dr Reddys Laboratories Inc)
The FDA approved a generic FINASTERIDE product from Dr Reddys Laboratories Inc under an original ANDA.
-
FDA approval · 2013-07-01FDA Approved: FINASTERIDE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approves Sun Pharmaceutical Industries' generic finasteride under an original application (ANDA 090508), with indications including beni…
-
FDA approval · 2013-05-29FDA Approved: HAIR REGROWTH TREATMENT EXTRA STRENGTH FOR MEN — Supplemental Application (Seiseidou America, Inc.)
FDA approved a supplemental application for an extra-strength minoxidil hair regrowth product for men from Seiseidou America, Inc. (ANDA0755…
-
CLINICAL_TRIALS trial_result · 2013-05-13Clinical Trial Update: Effect of Pumpkin Seed Oil on Hair Growth in Men With Androgenetic Alopecia [NA]
This completed clinical trial evaluated the effect of pumpkin seed oil on hair growth in men with androgenetic alopecia.
-
FDA approval · 2013-04-26FDA Approved: FINASTERIDE — Supplemental Application (Accord Healthcare, Inc.)
FDA approved a supplemental application for finasteride submitted by Accord Healthcare, Inc.
-
FDA approval · 2013-04-25FDA Approved: FINASTERIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for finasteride from Teva Pharmaceuticals USA, Inc. The approval updates the labeling for the generi…
-
FDA approval · 2013-02-26FDA Approved: FINASTERIDE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for Finasteride from Aurobindo Pharma Limited, confirming approval of a generic version of finas…
-
FDA approval · 2013-02-22FDA Approved: FINASTERIDE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approves Camber Pharmaceuticals' supplemental ANDA for finasteride, a routine supplemental approval for a generic product.